-
1
-
-
35748960837
-
Unoperated patients with severe aortic stenosis
-
Bach DS, Cimino N, Deeb GM. Unoperated patients with severe aortic stenosis. J Am Coll Cardiol 2007;50:2018-9
-
(2007)
J Am Coll Cardiol
, vol.50
, pp. 2018-2019
-
-
Bach, D.S.1
Cimino, N.2
Deeb, G.M.3
-
2
-
-
80255137247
-
Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: The U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry
-
Moat NE, Ludman P, de Belder MA, et al. Long-term outcomes after transcatheter aortic valve implantation in high-risk patients with severe aortic stenosis: the U.K. TAVI (United Kingdom Transcatheter Aortic Valve Implantation) Registry. J Am Coll Cardiol 2011;58:2130-8
-
(2011)
J Am Coll Cardiol
, vol.58
, pp. 2130-2138
-
-
Moat, N.E.1
Ludman, P.2
De Belder, M.A.3
-
3
-
-
77649212932
-
Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: Acute and late outcomes of the multicenter Canadian experience
-
Rodes-Cabau J, Webb JG, Cheung A, et al. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience. J Am Coll Cardiol 2010;55:1080-90
-
(2010)
J Am Coll Cardiol
, vol.55
, pp. 1080-1090
-
-
Rodes-Cabau, J.1
Webb, J.G.2
Cheung, A.3
-
4
-
-
34547919242
-
Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis
-
Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007;116:755-63
-
(2007)
Circulation
, vol.116
, pp. 755-763
-
-
Webb, J.G.1
Pasupati, S.2
Humphries, K.3
-
5
-
-
77958594295
-
Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery
-
Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med 2010;363:1597-607
-
(2010)
N Engl J Med
, vol.363
, pp. 1597-1607
-
-
Leon, M.B.1
Smith, C.R.2
MacK, M.3
-
6
-
-
84860494889
-
Transcatheter aortic-valve replacement for inoperable severe aortic stenosis
-
Makkar RR, Fontana GP, Jilaihawi H, et al. Transcatheter aortic-valve replacement for inoperable severe aortic stenosis. N Engl J Med 2012;366: 1696-704
-
(2012)
N Engl J Med
, vol.366
, pp. 1696-1704
-
-
Makkar, R.R.1
Fontana, G.P.2
Jilaihawi, H.3
-
7
-
-
84875731422
-
Transfemoral aortic valve replacement versus medical management in high risk patients with symptomatic aortic valve stenosis: Canadian cost-effectiveness analysis based on the PARTNER trial cohort B findings
-
(in press)
-
Hancock-Howard R, Feindel C, Rodes-Cabau J, et al. Transfemoral aortic valve replacement versus medical management in high risk patients with symptomatic aortic valve stenosis: Canadian cost-effectiveness analysis based on the PARTNER trial cohort B findings. J Med Econ (in press)
-
J Med Econ
-
-
Hancock-Howard, R.1
Feindel, C.2
Rodes-Cabau, J.3
-
8
-
-
84875753236
-
TAVI: Reveal the truth, the whole truth and nothing but the truth
-
(in press)
-
Neyt M, Van Brabandt H. TAVI: reveal the truth, the whole truth and nothing but the truth. J Med Econ (in press)
-
J Med Econ
-
-
Neyt, M.1
Van Brabandt, H.2
-
9
-
-
84879171204
-
Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: A Canadian perspective
-
doi:10.1016/j.jtcvs.2012.06.018. (Published online 16 July 2012.)
-
Doble B, Blackhouse G, Goeree R, et al. Cost-effectiveness of the Edwards SAPIEN transcatheter heart valve compared with standard management and surgical aortic valve replacement in patients with severe symptomatic aortic stenosis: a Canadian perspective. J Thorac Cardiovasc Surg 2012; doi:10.1016/j.jtcvs.2012. 06.018. (Published online 16 July 2012.)
-
(2012)
J Thorac Cardiovasc Surg
-
-
Doble, B.1
Blackhouse, G.2
Goeree, R.3
-
10
-
-
84859796494
-
Markov model for selection of aortic valve replacement versus transcatheter aortic valve implantation (without replacement) in high-risk patients
-
Gada H, Kapadia SR, Tuzcu EM, et al. Markov model for selection of aortic valve replacement versus transcatheter aortic valve implantation (without replacement) in high-risk patients. Am J Cardiol 2012;109: 1326-33
-
(2012)
Am J Cardiol
, vol.109
, pp. 1326-1333
-
-
Gada, H.1
Kapadia, S.R.2
Tuzcu, E.M.3
-
11
-
-
84862210249
-
A cost-utility analysis of transcatheter aortic valve implantation in Belgium: Focusing on a well-defined and identifiable population
-
doi:10.1136/bmjopen-2012-001032
-
Neyt M, Van Brabandt H, Devriese S, et al. A cost-utility analysis of transcatheter aortic valve implantation in Belgium: focusing on a well-defined and identifiable population. BMJ Open 2012;2. doi:10.1136/bmjopen-2012-001032.
-
(2012)
BMJ Open
, vol.2
-
-
Neyt, M.1
Van Brabandt, H.2
Devriese, S.3
-
12
-
-
84863230665
-
Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: Results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B)
-
Reynolds MR, Magnuson EA, Wang K, et al. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B). Circulation 2012;125: 1102-9
-
(2012)
Circulation
, vol.125
, pp. 1102-1109
-
-
Reynolds, M.R.1
Magnuson, E.A.2
Wang, K.3
-
13
-
-
84857113470
-
Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement
-
Watt M, Mealing S, Eaton J, et al. Cost-effectiveness of transcatheter aortic valve replacement in patients ineligible for conventional aortic valve replacement. Heart 2012;98:370-6
-
(2012)
Heart
, vol.98
, pp. 370-376
-
-
Watt, M.1
Mealing, S.2
Eaton, J.3
-
14
-
-
84857884549
-
Cost-effectiveness of transcatheter aortic valve replacement
-
Hlatky MA, Simons CT. Cost-effectiveness of transcatheter aortic valve replacement. Circulation 2012;125:1076-7
-
(2012)
Circulation
, vol.125
, pp. 1076-1077
-
-
Hlatky, M.A.1
Simons, C.T.2
-
15
-
-
80255135508
-
Health related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis
-
Reynolds MR, Magnuson EA, Lei Y, et al. Health related quality of life after transcatheter aortic valve replacement in inoperable patients with severe aortic stenosis. Circulation 2011;124:1964-72
-
(2011)
Circulation
, vol.124
, pp. 1964-1972
-
-
Reynolds, M.R.1
Magnuson, E.A.2
Lei, Y.3
-
16
-
-
84862011904
-
Cost-effectiveness of transcatheter aortic valve replacement: Overoptimistic study results and a call for publication of complete trial results
-
Neyt M, Van Brabandt H. Cost-effectiveness of transcatheter aortic valve replacement: overoptimistic study results and a call for publication of complete trial results. Heart 2012;98:1031-3
-
(2012)
Heart
, vol.98
, pp. 1031-1033
-
-
Neyt, M.1
Van Brabandt, H.2
-
17
-
-
84864530669
-
Transcatheter aortic valve implantation (TAVI): Risky and costly
-
Van Brabandt H, Neyt M, Hulstaert F. Transcatheter aortic valve implantation (TAVI): risky and costly. BMJ 2012;345:e4710
-
(2012)
BMJ
, vol.345
-
-
Van Brabandt, H.1
Neyt, M.2
Hulstaert, F.3
-
18
-
-
84875747994
-
The Edwards SAPIEN THV Transcatheter Heart Valve System for patients with severe aortic stenosis who are not candidates for conventional open-heart aortic valve replacement surgery
-
U.S. Food and Drug Administration Accessed October 25, 2012
-
U.S. Food and Drug Administration. The Edwards SAPIEN-THV Transcatheter Heart Valve System for patients with severe aortic stenosis who are not candidates for conventional open-heart aortic valve replacement surgery. Briefing document for the Circulatory Systems Device Panel Advisory Committee. http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeeting Materials/MedicalDevices/MedicalDevicesAdvisoryCommittee/Circulatory SystemDevicesPanel/UCM262935.pdf. Accessed October 25, 2012
-
Briefing Document for the Circulatory Systems Device Panel Advisory Committee
-
-
-
19
-
-
84855583224
-
Transcatheter aortic valve implantation: Assessing the learning curve
-
Alli OO, Booker JD, Lennon RJ, et al Transcatheter aortic valve implantation: assessing the learning curve. JACC. Cardiovasc Interv 2012;5:72-9
-
(2012)
JACC. Cardiovasc Interv
, vol.5
, pp. 72-79
-
-
Alli, O.O.1
Booker, J.D.2
Lennon, R.J.3
-
20
-
-
84863337787
-
2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement
-
Holmes Jr. DR, Mack MJ, Kaul S, et al. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement. J Am Coll Cardiol 2012;59:1200-54
-
(2012)
J Am Coll Cardiol
, vol.59
, pp. 1200-1254
-
-
Holmes Jr., D.R.1
MacK, M.J.2
Kaul, S.3
-
21
-
-
81255208609
-
Rational dispersion for the introduction of transcatheter valve therapy
-
Mack MJ, Holmes Jr DR,. Rational dispersion for the introduction of transcatheter valve therapy. JAMA 2011;306:2149-50
-
(2011)
JAMA
, vol.306
, pp. 2149-2150
-
-
MacK, M.J.1
Holmes Jr., D.R.2
-
22
-
-
84884487669
-
New data from PARTNER continued access (Non-randomized): Transapical outcomes after TAVR
-
(abstract presentation October 22 2012 (Miami FL))
-
Dewey TM. New data from PARTNER continued access (Non-randomized): transapical outcomes after TAVR. Transcatheter Therapeutics 2012; (abstract presentation, October 22, 2012 (Miami, FL))
-
(2012)
Transcatheter Therapeutics
-
-
Dewey, T.M.1
-
23
-
-
84875737950
-
New data from the PARTNER continued access (Non-randomized): Transfemoral outcomes after TAVR
-
(abstract presentation October 22 2012 (Miami FL))
-
Kodali S. New data from the PARTNER continued access (Non-randomized): Transfemoral outcomes after TAVR. Transcatheter Therapeutics 2012; (abstract presentation October 22, 2012 (Miami, FL))
-
(2012)
Transcatheter Therapeutics
-
-
Kodali, S.1
-
24
-
-
84862011069
-
Transcatheter Aortic Valve Implantation (TAVI): A health technology assessment update
-
Available at Accessed February 12, 2013
-
Neyt M, Van Brabandt H, Van de Sande S, et al. Transcatheter Aortic Valve Implantation (TAVI): a health technology assessment update. KCE Reports. 2011. p 163. Available at http://www.kce.fgov.be/content/kce-reports. Accessed February 12, 2013
-
(2011)
KCE Reports
, pp. 163
-
-
Neyt, M.1
Van Brabandt, H.2
Van De Sande, S.3
-
25
-
-
84871301406
-
Cost effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high risk patients with severe aortic stenosis: Results from the PARTNER Trial (Cohort A)
-
Reynolds MR, Magnuson EA, Lei Y, et al. Cost effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high risk patients with severe aortic stenosis: results from the PARTNER Trial (Cohort A). J Am Coll Cardiol 2012;60:2683-92
-
(2012)
J Am Coll Cardiol
, vol.60
, pp. 2683-2692
-
-
Reynolds, M.R.1
Magnuson, E.A.2
Lei, Y.3
-
26
-
-
84864774776
-
Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: Results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A)
-
Reynolds MR, Magnuson EA, Wang K, et al. Health-related quality of life after transcatheter or surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results from the PARTNER (Placement of AoRTic TraNscathetER Valve) Trial (Cohort A). J Am Coll Cardiol 2012;60:548-58
-
(2012)
J Am Coll Cardiol
, vol.60
, pp. 548-558
-
-
Reynolds, M.R.1
Magnuson, E.A.2
Wang, K.3
|